Do you see any chance that if P3 holistically fails, the drug could still get approved for a more limited clinical approach, like PCV or occult? In footy terms, if P3 doesn’t kick a goal, could we at least get a point instead of being out of bounds on the full? What do you think?
- Forums
- ASX - By Stock
- Opthea Q and A
Do you see any chance that if P3 holistically fails, the drug...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
54.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $670.9M |
Open | High | Low | Value | Volume |
54.5¢ | 56.0¢ | 53.8¢ | $768.2K | 1.408M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 36501 | 54.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 99019 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 37010 | 0.540 |
7 | 23010 | 0.535 |
9 | 43432 | 0.530 |
9 | 98697 | 0.525 |
11 | 184194 | 0.520 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 99071 | 17 |
0.550 | 31126 | 8 |
0.555 | 19002 | 6 |
0.560 | 98746 | 13 |
0.565 | 102846 | 6 |
Last trade - 15.52pm 27/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online